EUVIMEDEUVIMED entdecken
Crossref

Monitoring Community Use of Benzodiazepines Through Wastewater‐Based Epidemiology

Maarten Quireyns iD, Tim Boogaerts, Natan Van Wichelen, Diāna Vanaga-Arāja, Olesia Rudminienė, Ruxanda Iliescu, Milica Georgescu, Sofie Schaerlaekens, Naomi De Roeck, Peter Delputte, Adrian Covaci, Alexander L N van Nuijs iD

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Maarten Quireyns und 11 weiteren Autor:innen. Beteiligte Einrichtung: Toxicological Centre, University of Antwerp, Wilrijk, Belgium. Hauptthemen laut MEDLINE: Benzodiazepines, Wastewater, Water Pollutants, Chemical, Substance Abuse Detection. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Research Foundation-Flanders, University of Antwerp, Universiteit Antwerpen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benzodiazepines and related z‐drugs (BZDs) are widely used pharmaceuticals but require careful monitoring due to limited efficacy, tolerance development and the risk of dependence. Wastewater‐based epidemiology (WBE) is a valuable approach to gather population‐wide information on consumption patterns through analysis of influent wastewater. This study examines how overlapping metabolic pathways within the BZD drug class can lead to misinterpretation if not carefully considered. An analytical method is developed and validated for 26 biomarkers of prescription BZDs in influent wastewater using solid‐phase extraction and liquid chromatography–tandem mass spectrometry and applied to influent wastewater samples for the first time in Belgium (13 locations), Latvia (1), Lithuania (3) and Romania (1). The countries were chosen for their differing prescription BZD market registration, allowing testing of different hypotheses. To aid in complex data interpretation, this study presents a structured categorisation of BZDs into direct biomarkers, which directly reflect consumption, and downstream biomarkers, which are influenced by multiple BZDs, and further discusses the implication this has on the interpretation. Spatial differences were noted among direct biomarkers such as higher consumption of zolpidem in Belgium and zopiclone in Riga (LVA). Downstream biomarkers had higher population‐normalised mass loads but cannot be interpreted in isolation, for example, lorazepam (ranging 4–25 mg/day/1000 inhabitants over all locations), lormetazepam (8–30), oxazepam (10–50) and temazepam (1–12). These findings highlight challenges in interpreting BZD consumption trends and emphasise the need of distinguishing different biomarker classes to ensure accurate and comparable results across studies needed to guide informed decision‐making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzodiazepinesWastewaterWater Pollutants, ChemicalSubstance Abuse DetectionWastewater-Based Epidemiological MonitoringHumansTandem Mass SpectrometrySolid Phase ExtractionChromatography, LiquidBiomarkers

Stichwörter der Autor:innen

benzodiazepinesconsumption estimatesliquid chromatography–tandem mass spectrometrymetabolic pathwayswastewater surveillance

Substanzen

BenzodiazepinesWastewaterWater Pollutants, ChemicalBiomarkers

Autor:innen und Institutionen

  • Toxicological Centre, University of Antwerp, Wilrijk, Belgium.
  • Slimību Profilakses un Kontroles Centrs, Riga, Latvia.
  • Narkotikų, Tabako ir Alkoholio kontrolės Departamentas, Vilnius, Lithuania.
  • Agenția Națională Antidrog, Bucharest, Romania.
  • Laboratory for Microbiology, Parasitology and Hygiene, University of Antwerp, Wilrijk, Belgium.

ORCID-Profile: Maarten Quireyns, Alexander L N van Nuijs

Förderung

  • Research Foundation-Flanders
  • University of Antwerp
  • Universiteit Antwerpen

Zitieren

APA

Quireyns, M., Boogaerts, T., Van Wichelen, N., Vanaga-Arāja, D., Rudminienė, O., Iliescu, R., Georgescu, M., Schaerlaekens, S., De Roeck, N., Delputte, P., Covaci, A., & van Nuijs, A. L. N. (2025). Monitoring Community Use of Benzodiazepines Through Wastewater‐Based Epidemiology. Drug Testing and Analysis. https://doi.org/10.1002/dta.3915

Vancouver

Quireyns M, Boogaerts T, Van Wichelen N, Vanaga-Arāja D, Rudminienė O, Iliescu R, et al. Monitoring Community Use of Benzodiazepines Through Wastewater‐Based Epidemiology. Drug Testing and Analysis. 2025. doi:10.1002/dta.3915

BibTeX
@article{Quireyns2025,
  author = {Quireyns, Maarten and Boogaerts, Tim and Van Wichelen, Natan and Vanaga-Arāja, Diāna and Rudminienė, Olesia and Iliescu, Ruxanda and Georgescu, Milica and Schaerlaekens, Sofie and De Roeck, Naomi and Delputte, Peter and Covaci, Adrian and van Nuijs, Alexander L N},
  title = {Monitoring Community Use of Benzodiazepines Through Wastewater‐Based Epidemiology},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3915}
}
Kostenlos starten →